Evaluating the impact of transpulmonary mechanical power on patients with severe ARDS on ECMO
Official title: Effect of Transpulmonary Mechanical Power on the Prognosis of Patients With Severe Acute Respiratory Distress Syndrome Treated With Venovenous Extracorporeal Membrane Oxygenation
Run by Beijing Chao Yang Hospital · NCT06062212 · Data updated 2026-11-12
This study is trying to see if measuring the power of breathing machines can help doctors predict how well patients with severe lung problems on ECMO will do and improve their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Beijing Chao Yang Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | October 1, 2023 |
| Main results expected | December 30, 2027 |
| Study ends | April 30, 2028 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT06062212 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with severe ARDS who are currently receiving VV-ECMO support.
✕Probably not a fit
Patients who have been on high pressure ventilation for more than 7 days or have severe chronic lung disease with a life expectancy of less than 6 months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the role of transpulmonary mechanical power in predicting the prognosis of patients suffering from severe acute respiratory distress syndrome (ARDS) who are receiving venovenous extracorporeal membrane oxygenation (VV-ECMO). The study aims to understand how mechanical ventilation settings can affect patient outcomes and the potential for ventilator-related lung injury. By focusing on transpulmonary pressure, the research seeks to provide insights into optimizing treatment strategies for ARDS patients on ECMO. The findings could help improve the management of these critically ill patients.
Why it matters
Potential benefit: If successful, this study could lead to improved prognostic assessments and treatment strategies for patients with severe ARDS, potentially reducing mortality rates.
How similar studies have gone: While the specific approach of assessing transpulmonary mechanical power is novel, studies on mechanical ventilation and ECMO have shown varying degrees of success in improving patient outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Meet the diagnostic criteria of Berlin's definition for ARDS; 2. Receiving VV-ECMO support. Exclusion Criteria: 1. Patients had been on high pressure (Ppeak \>35 cm H2O) and a high fraction of inspired oxygen (FiO2\>0.8) ventilation for \>7 days; 2. Patients had a contraindication to heparinization; 3. Patients had an irreversible neurological injury; 4. Patients had severe chronic lung disease with life expectancy \<6 months.
Where it's running
-
Beijing Chao-Yang Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Yu Zhao, Dr.
- Email: xuanben1985@163.com
- Phone: +8618601342030
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimizing blood flow in patients on veno-venous ECMO
This study is testing if adjusting blood flow during ECMO treatment can help patients with severe breathing problems get better oxygen without needing as much blood flow.
-
Full-Course ECMO Pathway for Moderate-to-Severe ARDS
This study tests a standardized, full-course ECMO management pathway to see if it improves care for adults with moderate-to-severe ARDS treated with VV-ECMO in real-world Chinese centers.
-
How ventilator modes affect abdominal pressure and tube tolerance in ICU patients
This observational study tests how different mechanical ventilation modes influence intra-abdominal pressure and gastric tube tolerance in adults who need ventilation in the ICU.
-
Height measurement methods to guide ventilator settings in ARDS
We’re testing whether more precise height measurements change how researchers set lung-protective tidal volumes in adults with ARDS who are on a ventilator.
-
Corticosteroids for a hyperinflammatory state in critical illness
This trial tests whether methylprednisolone helps improve organ function and survival in adults with sepsis or ARDS who show a hyperinflammatory profile.
-
Right‑heart function and heart–lung interaction during ARDS with mechanical ventilation
This project will follow adults with ARDS on mechanical ventilation to see how positive‑pressure breathing affects the right heart over time and how that relates to circulation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.